The FDA is alerting health care providers to the recall of certain VasoView HemoPro devices due to risk of silicone detachment during use, and supply concerns.
Similar Posts
Examples of Accepted Emerging Technologies
CDER’s Office of Pharmaceutical Quality created the Emerging Technology Program to promote the adoption of innovative approaches to pharmaceutical product design and manufacturing.Velocity Pharma LLC – 676434 – 07/17/2024
CGMP/Finished Pharmaceuticals/AdulteratedRegistered Outsourcing Facilities
Discover FDA’s comprehensive list of registered outsourcing facilities engaged in human drug compounding. Get the latest updates, compliance guidelines, and resources to ensure safe, high-quality compounded medications. Explore regulations and stay informed with verified facility details.Treating and Preventing Head Lice
Head lice affect millions of children every year. Although head lice are a year-round problem, cases usually peak during back-to-school time. FDA-approved treatments for head lice include over-the-counter and prescription drugs.Coronavirus (COVID-19) Update: Daily Roundup April 13, 2020
Coronavirus (COVID-19) Update: Daily RoundupInvestigational New Drug (IND) Application
Get to know the investigational new drug application (IND). This includes the types, laws and regulations, and emergency use of INDs.